-transparent.png){kind=logo}
The long-acting somatostatin analogue octreotide was used in a patient with severe orthostatic hypotension resistant to conventional treatment. 0.4 ug/kg octreotide given subcutaneously abolished the postural drop in systolic blood pressure for about four hours and was more effective than a combination of fludrocortisone and pindolol.
Related Publications
J Woo, and
K H Or, and
R Teoh, and
M G Nicholls
June 1989,
The Journal of clinical endocrinology and metabolism,
J Woo, and
K H Or, and
R Teoh, and
M G Nicholls
November 1991,
The British journal of surgery,
J Woo, and
K H Or, and
R Teoh, and
M G Nicholls
September 1987,
The American journal of medicine,
J Woo, and
K H Or, and
R Teoh, and
M G Nicholls
February 1998,
The Journal of clinical endocrinology and metabolism,
J Woo, and
K H Or, and
R Teoh, and
M G Nicholls
October 2001,
Nihon rinsho. Japanese journal of clinical medicine,
J Woo, and
K H Or, and
R Teoh, and
M G Nicholls
January 1999,
The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique,
J Woo, and
K H Or, and
R Teoh, and
M G Nicholls
June 1999,
Endocrine journal,
J Woo, and
K H Or, and
R Teoh, and
M G Nicholls
November 1992,
Gut,
J Woo, and
K H Or, and
R Teoh, and
M G Nicholls
April 1994,
Presse medicale (Paris, France : 1983),
J Woo, and
K H Or, and
R Teoh, and
M G Nicholls
January 2002,
Hormones (Athens, Greece),
